Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 InfectionCase Report Published on 2022-01-272022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] autoinflammatory disease combination therapy Contracting Corticosteroids COVID-19 COVID-19 pandemic cyclosporine diagnosed disorders dosage effective High-dose Immunosuppression immunosuppressive immunosuppressive therapy infected with COVID-19 Infection Inflammation initial Methylprednisolone neutrophil Patient physician pyoderma Pyoderma gangrenosum the patient therapeutic strategy Treatment wound healing [DOI] 10.3390/jpm12020173 PMC 바로가기 [Article Type] Case Report
Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy AdultCase Report Published on 2022-01-072022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adverse event BNT162b2 BNT162b2 vaccine characteristic continuous monitoring Coronavirus disease 2019 COVID-19 COVID-19 vaccine Cutaneous manifestations described develop edema epidermal etiology first dose hospital immunosuppressive induced infiltration Inflammation Inflammatory manifestation mRNA mRNA vaccine mRNA vaccines Necrosis neutrophilic Patient Pfizer/BioNTech pyoderma Pyoderma gangrenosum receiving skin skin lesion Surveillance therapy ulcerative Vaccine variety [DOI] 10.3390/vaccines10010087 PMC 바로가기 [Article Type] Case Report
Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in patients with ANCA-associated vasculitis and COVID-19Case Report Published on 2022-01-052022-11-01 Journal: Clinical Nephrology. Case Studies [Category] COVID-19, [키워드] African ANCA association COVID-19 Cyclophosphamide described diagnosed died disease Evolution Hydroxychloroquine immunosuppressive infection with SARS-CoV-2 Injury Occurrence Patient potential risk recurrence Respiratory failure SARS-COV-2 infection therapy treated Treatment triggered Vasculitis viral infection with COVID-19 [DOI] 10.5414/CNCS110567 PMC 바로가기 [Article Type] Case Report
Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab오크렐리주맙으로 치료받은 다발성 경화증 환자에서 SARS-CoV-2 백신 접종에 대한 체액 및 T 세포 반응Article Published on 2022-01-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] MERS, SARS, 진단, 치료기술, [키워드] Absolute lymphocyte count adaptive Adaptive Biotechnology age analyzed anti-CD20 therapy Anti-SARS-CoV-2 S antibodies antibody Antibody Response B and T-cell BMI CD19 characterized chemotherapeutic agents cohort study comparator conducted coronavirus coronavirus vaccine COVID COVID-19 COVID-19 epidemic Descriptive statistics detectable determine did not produce Efficacy Elecsy Eligible patients enrolled Enrollment evaluate Fisher Fisher's exact test had no humoral Humoral response IgG immune response immunoassay immunogenicity Immunoglobulin Immunoglobulin G immunosuppressive impair Infection likelihood lymphocyte Multiple multiple sclerosis Natalizumab negative antibody response no correlation Ocrelizumab Patient patients patients treated positive positive antibody response post vaccination Prevent producing question raise reduce Research response Roche SAR-CoV-2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccination severity Sex shown single center T-cell T-cell Response T-cell responses Test the antibody response treated Treatment vaccination Vaccine vaccine immunogenicity variable was performed were excluded Wilcoxon rank sum [DOI] 10.1016/j.msard.2021.103382 PMC 바로가기 [Article Type] Article
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients간 이식 환자에서 SARS-CoV2 mRNA 2회 접종 후 조정된 세포 및 체액 면역 반응Article Published on 2022-01-012022-09-12 Journal: Liver international : official journal of the Inte [Category] MERS, SARS, 진단, [키워드] Anti-spike anti-spike titre antibody benefit cell-mediated immune cell-mediated response cellular Control correlated cytokine production described dose healthy controls humoral humoral immune response Humoral response IFN-γ IL-2 immune immunosuppressive Infectious diseases Italian Limited liver liver transplant mRNA vaccination mRNA vaccine Neutralizing PBMC Predictive proliferation recipient recipients reduced regimen response response to vaccination risk SARS-CoV2 SARS-CoV2 vaccination solid organ transplant Specific T-cell T-cell immune response vaccination was measured [DOI] 10.1111/liv.15089 PMC 바로가기 [Article Type] Article
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome전향적으로 추적한 베체트 증후군 환자 코호트에서 COVID-19의 발병률, 임상적 특징 및 결과Article Published on 2022-01-012022-09-11 Journal: Rheumatology International [Category] 치료제, [키워드] 95% CI adjusted age and gender Anosmia Anticoagulants arthralgia Asymptomatic Behcet's disease case sery Clinical characteristics Clinical outcome Cohort cohort of patient Colchicine Complete COVID-19 COVID-19 infection cumulative cumulative incidence defined died disease course dose drug discontinuation exacerbate fatigue Favipiravir Fever Follow-up followed by General population headache Hospitalized Hydroxychloroquine immunosuppressive incidence incidence of COVID-19 indicated infected with SARS-CoV-2 Infection information intensive care intensive care unit interferon interferon-alpha İstanbul laboratory-confirmed large cohort likelihood lung involvement management median Mortality Multiple Multiple regression analysis not differ outcome outpatient clinic pandemic Patient patients PCR positive positive Prognosis Prospective Study protective effect Registered regression analysis remaining reported SARS-CoV-2 SARS-CoV-2 PCR severity of COVID-19 Significant significantly smoking Symptom syndrome tested the patient thrombotic thrombotic event Thrombotic events took place Treatment Turkey were given [DOI] 10.1007/s00296-021-05056-2 PMC 바로가기 [Article Type] Article
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients간경변 및 이식 환자에서 2차 예방접종 후 SARS-CoV 2 특이 체액 및 T 세포 면역 반응Article Published on 2022-01-012022-09-12 Journal: Clinical gastroenterology and hepatology : the off [Category] SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome age anti-S anti-SARS-CoV-2 anti-SARS-CoV-2 titer Arterial hypertension booster vaccinations cirrhosis Cohort Control controls coronavirus develop DiaSorin Effect Elecsy Euroimmun healthy control Heterologous humoral identify immune response immunoassay Immunosuppression immunosuppressive information inhibitor less LIAISON liver Liver cirrhosis liver transplant recipients Logistic regression analysis monotherapy Odds ratio Patient patient groups predictor prospective cohort study RBD recipient recipients reduction regimen Research response Roche routine SARS-CoV-2 SARS-CoV-2 vaccination second second vaccination Seroconversion Serological testing spike-protein spike-specific T-cell response T-cell T-cell Response Transplant trimer vaccination was performed [DOI] 10.1016/j.cgh.2021.09.003 PMC 바로가기 [Article Type] Article
Impact of COVID-19 in immunosuppressive drug-naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease면역 억제 약물-나이브자가 면역 장애에서 Covid-19의 영향 :자가 면역 위염, 체강 질병, 1 형 당뇨병 및자가 면역 갑상선 질환Article Published on 2022-01-012022-08-31 Journal: Pediatric allergy and immunology : official public [Category] SARS, 치료제, [키워드] adverse outcomes Autoimmune Autoimmune diseases Autoimmune disorders autoimmune gastritis autoimmune thyroid disease Autoimmunity celiac disease comparable conducted COVID-19 diabete diabetes died disease gastritis General population Hospitalization immunosuppressive immunosuppressive drugs Impact indicated lombardy Mild molecular Nasopharyngeal swab nasopharyngeal swabs outcome Patient patients patients required hospitalization performed positive COVID-19 reported risk SARS-CoV-2 SARS-COV-2 infection serology Seven susceptibility T1D telephone Thyroid thyroid disease Treatment Type 1 diabetes vaccination Vaccination Status [DOI] 10.1111/pai.13646 PMC 바로가기 [Article Type] Article
COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response신장 질환이 있는 소아 및 젊은 성인의 COVID-19: 위험 인자, 임상 특징 및 혈청학적 반응Article Published on 2022-01-012022-09-11 Journal: Journal of Nephrology [Category] SARS, 치료기술, [키워드] 95% CI Adult patients Adults anti-SARS-CoV-2 antibodies antibody Asymptomatic children chronic Chronic kidney disease CKD clinical feature Cohort collected coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 incidence COVID-19 severity develop disease Factor General population glomerular glomerular disease Hospitalized Immunosuppression immunosuppressive immunosuppressive therapy incidence Infection kidney Kidney disease Kidney function kidney transplant recipient kidney transplant recipients Kidney transplantation Mild mild symptoms Modification morbidity and mortality nephrotic syndrome number of household observation on children pandemic Patient patient population PCR testing PCR-confirmed COVID-19 recurrent infection remained risk factor Risk factors serological response severity severity of COVID-19 socio-demographic study population Symptoms tested therapy treated Treatment with COVID-19 [DOI] 10.1007/s40620-021-01171-2 PMC 바로가기 [Article Type] Article
Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agentsArticle Published on 2022-01-012022-11-15 Journal: Pediatrics international : official journal of the [Category] SARS, 진단, [키워드] acute respiratory syndrome Administered adolescents Adverse adverse event antibody Antibody titer Antibody titers Breakthrough infection children clinical effectiveness conducted coronavirus defined diagnosed disease domain dose enrolled evaluated event Factor FIVE immunogenic immunogenicity immunosuppressants immunosuppressive immunosuppressive agent Immunosuppressive agents Infection interquartile range median median age Messenger RNA mRNA mRNA vaccine non-recipient non-specific occurred Patient patients postvaccination Prospective Study recipient recipients rejection SARS-CoV-2 SARS-CoV-2 mRNA vaccine SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 vaccine significantly lower solid organ transplant Solid organ transplant recipients SOT titer vaccination Vaccine Vaccine failure was measured were measured [DOI] 10.1111/ped.15331 PMC 바로가기